000 | 01942 a2200565 4500 | ||
---|---|---|---|
005 | 20250517152524.0 | ||
264 | 0 | _c20180626 | |
008 | 201806s 0 0 eng d | ||
022 | _a1538-8514 | ||
024 | 7 |
_a10.1158/1535-7163.MCT-16-0821 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCooper, Jonathan | |
245 | 0 | 0 |
_aCombined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses _h[electronic resource] |
260 |
_bMolecular cancer therapeutics _c08 2017 |
||
300 |
_a1693-1704 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarcinogenesis _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCyclopentanes _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aMesothelioma _xdrug therapy |
650 | 0 | 4 | _aMesothelioma, Malignant |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMutation _xgenetics |
650 | 0 | 4 |
_aNeurofibromin 2 _xmetabolism |
650 | 0 | 4 | _aOncogenes |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
650 | 0 | 4 |
_aPleural Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aUbiquitin-Activating Enzymes _xantagonists & inhibitors |
700 | 1 | _aXu, Qingwen | |
700 | 1 | _aZhou, Lu | |
700 | 1 | _aPavlovic, Milica | |
700 | 1 | _aOjeda, Virginia | |
700 | 1 | _aMoulick, Kamalika | |
700 | 1 | _ade Stanchina, Elisa | |
700 | 1 | _aPoirier, John T | |
700 | 1 | _aZauderer, Marjorie | |
700 | 1 | _aRudin, Charles M | |
700 | 1 | _aKarajannis, Matthias A | |
700 | 1 | _aHanemann, C Oliver | |
700 | 1 | _aGiancotti, Filippo G | |
773 | 0 |
_tMolecular cancer therapeutics _gvol. 16 _gno. 8 _gp. 1693-1704 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-16-0821 _zAvailable from publisher's website |
999 |
_c27138626 _d27138626 |